Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothTicagrelor 90mg
Brilinta 90mg Tablet 14s
You Searched
Brilinta 90mg Tablet 14s
AstraZeneca
₹591
Our Recommendation
Ticavue 90mg Tablet 14s
4,170+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Prevention of heart attack and stroke
Customers also bought
More About Brilinta
Benefits
In Prevention of heart attack and stroke Brilinta 90mg Tablet is an antiplatelet medicine or blood thinner. It prevents blood from clotting inside the veins and arteries. This helps the blood flow freely around your body thereby preventing a heart attack or stroke (or deep vein thrombosis or pulmonary embolism). Take this medicine regularly and make appropriate lifestyle changes to achieve maximum benefits. It is often prescribed along with a low dose of aspirin which also helps to prevent blood from clotting.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Brilinta 90mg Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Brilinta 90mg Tablet is an antiplatelet medication. It works by preventing platelets from sticking together, thereby decreasing the formation of harmful blood clots. This lowers the chance of heart attack or stroke.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Brilinta 90mg Tablet 14 Tablet .
Seek medical advice from your doctor: Brilinta 90mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Information regarding the use of Brilinta 90mg Tablet during breastfeeding is not available. Doctor consultation is advised.
SAFE - Brilinta 90mg Tablet does not usually affect your ability to drive.
Safe when prescribed by an expert: Brilinta 90mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Brilinta 90mg Tablet is recommended. Limited information is available on the use of Brilinta 90mg Tablet in renal dialysis patients.
Caution Advised: Brilinta 90mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Brilinta 90mg Tablet may be needed. Doctor consultation is advised. Use of Brilinta 90mg Tablet is not recommended in patients with severe liver disease.
What if I forget to take it?
If a dose of Brilinta 90mg Tablet 14 Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Corporate & Registered Office, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, 560045, Bangalore
References
Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 871-72
Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 351-52
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1359-60
Ticagrelor. Luton, Bedfordshire: AstraZeneca UK Limited; 2010 (24 Jan. 2019)
Ticagrelor. Wilmington, Delaware: AstraZeneca LP; 2015 (20 Mar. 2019)
Ticagrelor. Wilmington, Delaware: AstraZeneca LP; 2011 (19 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (19 Mar. 2019)
Ticagrelor (07 Aug. 2023)
Ticagrelor (Oct. 10, 2024)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.